Several leading diagnostics companies and laboratories are providing or developing plasma pTau blood biomarker tests (especially pTau217) for human clinical assessment of Alzheimer’s disease:

Labcorp

  • Labcorp offers pTau217 and related Alzheimer’s blood biomarker testing as part of a robust neurology portfolio for clinical use.

Other Laboratories